* Present address: To whom reprint requests should be addressed at the Department of Surgery, the Jewish Hospital of St Louis, 213 Sourth Kingshighway, St Louis, Missouri 63110, USA.
Froromectin (FN), a 420 kDa glycoprotein, consists of two similar subunits linked by a disulpthide bond near the C-terminal end. FN is present in soluble and matrix forms in various body fluids and tissues and has been shown to bind to a variety of organisms. We characterized the conditions required for 125I-FN binding to Bacille Calmette-Guérin (BCG). The binding was dose-dependent, reached saturation within 3 min, and was essentially irreversible for at least 24 h under optimal binding conditions at pH 6·0. In contrast, the binding was reversible (> 90% in 24 h) when the pH was increased to 10·0. Scatchard analysis of the dose-response expreiments produced a straight line, suggesting the presence of a single class of FN receptor on BCG. 125I-FN binding was trypsin-sensitive, suggesting that the BCG-binding molecule is a protein. The number of FN receptors was determined to be 8000–15000 per bacterium. 125I-FN binding was pH dependent, with maximal binding at acidic pH. 125I-FN binding was sensitive to the presence of NaCl, with 0·08 m-NaCl inhibiting binding by 85%. These data demonstrate that soluble FN binds to a trypsin-sensitive cell-surface component of BCG in an essentially irreversible manner.
CatalonaW.J.,
HudsonM.A.,
GillenD.P.,
AndrioleG.L.,
RatliffT.L.1987; Risks and benefits of repeated courses of intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer.. Journal of Urology 137:220–224
CourtneyH.S.,
OfekI.,
SimpsonW.A.,
HastyD.L.,
BeacheyE.H.1983; Binding of Streptococcus pyogenes to soluble and insoluble fibronectin.. Infection and Immunity 53:454–459
FrömanG.,
SwitalskiL.M.,
SpezialeP.,
HookM.1987; Isolation and characterization of a fibronectin receptor from Staphylococcus aureus.. Journal of Biological Chemistry 262:6564–6571
MoralesE.,
EidingerD.,
BruceA.W.1976; Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors.. Journal of Urology 116:180–183
MoriK.,
LammD.L.,
CrawfordE.D.1986; A trial of bacillus Calmette-Guérin versus Adriamycin in superficial bladder cancer. A South-west Oncology Group Study.. Urology International 41:254–259
PodeD.,
AlonY.,
HorowitzA.T.,
VlodavskyI.,
BiranS.1986; The mechanism of human bladder tumor implantation in an in vitro model.. Journal of Urology 136:482–486
PommierC.G.,
OsheaJ.,
ChusedT.,
YanceyK.,
FrankM.M.,
TakahashiT.,
BrownE.J.1984; Studies on the fibronectin receptors of human peripheral blood leukocytes.. Journal of Experimental Medicine 159:137–151
RatliffT.L.,
PalmerJ.O.,
McgarrJ.A.,
BrownE.J.1987; Intravesical bacille Calmette-Guérin (BCG) therapy for murine bladder tumors: initiation of the response by fibronectin mediated attachment of BCG.. Cancer Research 47:1762–1766
RatliffT.L.,
McgarrJ.A.,
Abou-ZeidC.,
RookG.A.W.,
StanfordJ.L.,
AslanzadehJ.,
BrownE.J.1988; Attachment of mycobacteria to fibronectin-coated surfaces.. Journal of General Microbiology 134:1307–1313